Organisation paid for research Program year 2023 Source: CMS Open Payments

Summit Research Group

Neither a doctor nor a teaching hospital

Research payments

$331,517

15 payments

Through program year 2023, Summit Research Group is reported as receiving $331,517 in research payments, across 15 payments.

By program year

5 rows

Year	Kind	Amount	Payments
2023	Research	$13,755	2
2022	Research	$167,932	2
2021	Research	$115,935	2
2020	Research	$6,379	2
2019	Research	$27,516	7

Breakdown

Who paid Research payments · program years 2019–2023

AstraZeneca Pharmaceuticals LP $299,936 7 payments
Kowa Research Institute, Inc. $25,202 6 payments
Novo Nordisk AS $6,379 2 payments

Studies the money was for Research payments · program years 2019–2023

Randomised Parallel Double Blind Placebo Controlled Phase 2b Study to Assess the Safety Tolerability and Efficacy of AZD8233 Treatment in Participants with Hyperlipidaemia SOLANO $297,622 6 payments
K-877-303 $14,615 3 payments
K-877-301 $10,587 3 payments
Cor-001-02 $6,379 2 payments
A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamic Effects of MEDI5884 in Adults With Stable Coronary Heart Disease $2,314 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.